FDA Inspection
Orly International, Inc.Orly International, Inc. – FDA Inspection, Dec 20, 2022
Record Details
This FDA Inspection record concerns Orly International, Inc., with an inspection on December 20, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Orly International, Inc.
- Inspection Date
- December 20, 2022
- Product Type
- Drugs
View Company Profile
ID · 614d8512-b800-4d3f-9cce-a8fd02291fae
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1193313
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
8- 21 CFR 211.137(a)Expiration date lacking
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.